At Cancilico, we are committed to revolutionizing the field of image-based diagnostics. Our vision is to harness the potential of artificial intelligence to streamline and improve the accuracy of critical diagnostic processes. With morphological differentiation of bone marrow smears being one key area of our focus, our innovative technology aims to bring a new era of precision and speed to the diagnosis of hematological cancers. In an industry where every second counts, our solutions promise to deliver faster, more reliable results, aiding clinicians in making timely and informed decisions, thereby enhancing patient care and outcomes.